Values First Advisors’s Guardant Health GH Stock Holding History

Values First Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Sell	20,765 -723	-3%	-$72.6K	1%	32
2025 Q4	$2.19M	Sell	21,488 -9,554	-31%	-$855K	1.14%	19
2025 Q3	$1.94M	Sell	31,042 -1,497	-5%	-$81.4K	1.04%	28
2025 Q2	$1.69M	Buy	32,539 +2,942	+10%	+$131K	0.92%	38
2025 Q1	$1.26M	Buy	29,597 +1,538	+5%	+$66.4K	0.74%	43
2024 Q4	$857K	Sell	28,059 -3,966	-12%	-$112K	0.47%	60
2024 Q3	$735K	Buy	32,025 +3,777	+13%	+$107K	0.4%	66
2024 Q2	$816K	Sell	28,248 -7,863	-22%	-$183K	0.49%	58
2024 Q1	$745K	Buy	36,111 +976	+3%	+$20.9K	0.44%	69
2023 Q4	$950K	Buy	35,135 +4,604	+15%	+$121K	0.57%	52
2023 Q3	$905K	Sell	30,531 -12,117	-28%	-$426K	0.58%	50
2023 Q2	$1.53M	Buy	42,648 +9,765	+30%	+$280K	0.92%	36
2023 Q1	$771K	Buy	32,883 +19,164	+140%	+$547K	0.49%	60
2022 Q4	$373K	Sell	13,719 -2,798	-17%	-$128K	0.26%	107
2022 Q3	$889K	Buy	16,517 +60	+0.4%	+$3.08K	0.64%	51
2022 Q2	$664K	Buy	16,457 +7,557	+85%	+$374K	0.47%	64
2022 Q1	$590K	Buy	8,900 +5,438	+157%	+$372K	0.37%	83
2021 Q4	$346K	Buy	+3,462	New	+$358K	0.2%	123

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Values First Advisors's GH Position: Q1 2026 in Review

Values First Advisors reduced its Guardant Health (GH) stake by 3.4% in Q1 2026, selling an estimated $72.6K and leaving 20,765 shares worth $1.92M. The position accounts for 1% of the portfolio, ranked #32.

Values First Advisors first reported a position in GH in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.19M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Values First Advisors held 20,765 shares of Guardant Health worth $1.92M as of Q1 2026.
Values First Advisors sold 723 Guardant Health shares in Q1 2026, an estimated $72.6K.
Guardant Health made up 1% of Values First Advisors's portfolio in Q1 2026, its #32 holding.
Values First Advisors first reported a position in Guardant Health in Q4 2021 and has held it in 18 quarters since.
Values First Advisors's Guardant Health position peaked at $2.19M in Q4 2025.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.